by smcork | Oct 11, 2012 | Commentary
When the Supreme Court upheld the constitutionality of the Patient Protection and Affordable Care Act on June 28, the impact was diverse and widespread. Relief was felt in one corner of the pharmaceutical industry, however, as the decision protected continued...
by vyc | Jan 9, 2010 | Commentary
On December 24, 2009, the Senate passed a landmark health care reform bill. Included within the Patient Protection and Affordable Care Act is the Biologics Price Competition and Innovation Act, which contains provisions for the regulation of cheaper versions of...
